We studied patients diagnosed with aspergillosis based on positive bronchoalveolar lavage (BAL) galactomannan (GM) who had follow-up BAL sampling within 180 days. GM trend and clinical outcome were concordant in only 60% (30/50). While useful for the initial diagnosis, BAL GM trending does not always correlate with treatment response.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10977621 | PMC |
http://dx.doi.org/10.1093/ofid/ofae114 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!